While it is still undecided who will be Dr. Scott Gottlieb's successor when he leaves the FDA in about a month, speculation about several candidates has emerged.
Pharmacy
The FDA this week approved a controversial drug to treat depression. While it is a novel antidepressant for people who do not respond to other treatments, it has also raised concerns of potential for its abuse.
CVS Caremark, the pharmacy benefits unit of CVS Health, will shut down a Nashville call center May 3, affecting 250 workers, according to the Nashville Business Journal.
Sen. Mike Braun, R-Ind., unveiled a bill to ban pharmacy rebates in the private market, according to The Washington Examiner.
Eight healthcare organizations — including UnitedHealth Group's OptumRx and Cigna's Pharmacy Management unit — were recognized March 5 by the Pharmacy Benefit Management Institute for their efforts and contributions to pharmacy management.
Advertisement
Consumers could save up to $5,400 a year by price shopping for their medications, according to a new study published by the U.S. Public Interest Research Group.
Introducing generic competition to the market has long been cited as a way to lower drug prices in the U.S.
OxyContin maker Purdue Pharma is considering filing for bankruptcy — a move that could complicate the legal battle over who's responsible for the opioid crisis, according to a STAT news report.
More than 100 value-based contracts were reached between payers and drug manufacturers between 2014 and 2017, suggesting that these contracts may be more prevalent than expected, according to a recent study published in the American Journal of Managed Care.
Hospital drug spending jumped 18.5 percent between 2015 and 2017, a rate which generated about $1.8 million in new costs for the average hospital. This comes on top of a 38 percent increase in inpatient drug spending per admission that…